Welcome To
LifeSci Capital
A research-driven investment bank with a sole focus on the life sciences
Learn more about LifeSci Capital in this short video
A New Model for Equity Research and Investor Engagement
Our team is dedicated to high quality, expert inspired equity research that compels investors to listen, read, engage, and convert into shareholders
48
Companies
Under coverage with an average market cap of $1,250M
71
Investor Events in 2022 & 2023
45 in person and 26 virtual
84
IPOs & Follow Ons
Average deal size $157M
232
Meetings
Average of 10 meetings per NDR
A Differentiated Model Focused on Quality
We generate thoroughly researched and insightful "deep dive" analyses that provide value to investors
Expert Driven
Expert engagement is at the core of our process, enabling us to have informed views on complex topics
Investor Engagement
We engage broadly with investors through our equity research and expansive non-deal roadshow activities
Our Advantage
A distinct influence over investor engagement and behavior
We pair in-depth equity research with customized equity capital markets activities to raise the visibility of covered companies and educate investors on compelling opportunities
Thoughtful, Transparent Advice
We provide deep sector knowledge by focusing exclusively on the Life Sciences, paired with extensive capital markets advisory experience, and informed views with our open research platform
Equity Research
Our research analysts hold advanced scientific or medical degrees and produce research that is widely read by the most prominent life science institutional investors
Investment Banking
LifeSci Capital equips clients with independent advisory services and experienced counsel to assist in making fully informed capital markets decisions
Equity Capital Markets
We use our research and research related activities to actively engage the investment community, first with our research analysts and ultimately with our clients